2022年重症监护药物治疗学重要文献
本文旨在总结2022年对重症患者药物治疗有重要影响的文献。通过系统检索PubMed/ MEDLINE及临床药学与药理学药物治疗文献更新,纳入2022年1月1日至12月31日发表的成人重症患者药物治疗干预并报告临床终点的随机对照试验、前瞻性研究或系统评价/Meta分析。共检索到704篇文献,排除660篇,剩余44篇按临床领域分层,经三轮改良德尔菲法在每个领域选出1篇最具影响力文献,最终纳入3项随机对照试验和3项系统评价/Meta分析,主题包括右美托咪定与其他镇静剂比较、β受体阻滞剂治疗、感染性休克静脉液体限制、静脉血栓栓塞预防、铜绿假单胞菌呼吸机相关性肺炎抗生素疗程及低剂量甲泼尼龙治疗重症社区获得性肺炎。
要点
- 本文纳入3项随机对照试验和3项系统评价/Meta分析,均为2022年发表的成人重症患者药物治疗研究。
- 主题涵盖右美托咪定与其他镇静剂在机械通气中的比较、重症患者β受体阻滞剂治疗、感染性休克静脉液体限制、重症成人静脉血栓栓塞预防、铜绿假单胞菌呼吸机相关性肺炎抗生素疗程及重症社区获得性肺炎低剂量甲泼尼龙治疗。
- 文献筛选采用三轮改良德尔菲法,基于对科学知识的总体贡献和新颖性在每个临床领域选出1篇最具影响力文献。
- 系统检索共获得704篇文献,排除660篇,最终44篇按临床领域分层。
适用人群与场景
- 成人重症患者,接受药物治疗干预并报告临床终点,文献发表于2022年1月1日至2022年12月31日。
研究设计与关键结果
- 系统检索PubMed/Medical Literature Analysis and Retrieval System Online及临床药学与药理学药物治疗文献更新,共获得704篇文献,排除660篇,剩余44篇按临床领域分层:急诊/神经病学、心血管、胃肠/液体/营养、血液、感染性疾病/免疫调节、内分泌/代谢。
- 经三轮改良德尔菲法在每个临床领域选出1篇最具影响力文献,最终纳入3项随机对照试验和3项系统评价/Meta分析。
- 总结的文献主题包括:机械通气期间右美托咪定与其他镇静剂比较、重症患者β受体阻滞剂治疗、感染性休克静脉液体限制、重症成人静脉血栓栓塞预防、铜绿假单胞菌呼吸机相关性肺炎抗生素疗程、重症社区获得性肺炎低剂量甲泼尼龙治疗。
证据类型、等级与局限
- 证据类型:综述,总结2022年发表的随机对照试验、前瞻性研究或系统评价/Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本文为文献综述,作者认为所总结的文献与重症患者药物治疗相关并可能影响临床实践。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: A number of trials related to critical care pharmacotherapy were published in 2022. We aimed to summarize the most influential publications related to the pharmacotherapeutic care of critically ill patients in 2022.
DATA SOURCES: PubMed/Medical Literature Analysis and Retrieval System Online and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update.
STUDY SELECTION: Randomized controlled trials, prospective studies, or systematic review/meta-analyses of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2022, and December 31, 2022, were included in this article.
DATA EXTRACTION: Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included and stratified into clinical domains based upon consistent themes. Consensus was obtained on the most influential publication within each clinical domain utilizing an a priori defined three-round modified Delphi process with the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature.
DATA SYNTHESIS: The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update yielded a total of 704 articles, of which 660 were excluded. The remaining 44 articles were stratified into the following clinical domains: emergency/neurology, cardiovascular, gastroenterology/fluids/nutrition, hematology, infectious diseases/immunomodulation, and endocrine/metabolic. The final article selected from each clinical domain was summarized following a three-round modified Delphi process and included three randomized controlled trials and three systematic review/meta-analyses. Article topics summarized included dexmedetomidine versus other sedatives during mechanical ventilation, beta-blocker treatment in the critically ill, restriction of IV fluids in septic shock, venous thromboembolism prophylaxis in critically ill adults, duration of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia, and low-dose methylprednisolone treatment in severe community-acquired pneumonia.
CONCLUSIONS: This concise review provides a perspective on articles published in 2022 that are relevant to the pharmacotherapeutic care of critically ill patients and their potential impact on clinical practice.
参考来源
- Gurnani PK, Barlow B, Boling B, et al. Major Publications in the Critical Care Pharmacotherapy Literature: 2022. Crit Care Explor. 2023. PMID: 37753239. doi:10.1097/CCE.0000000000000981
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。